The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Pieter Smits

Showing 1-20 of 23 articles
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial
Smits P, Chang C, Chevalier B, West N, Gori T, Barbato E, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Wlodarczak A, Abdel-Wahab M, Esposito G, Tijssen J, Morice M, Onuma Y, van Geuns R
October 23, 2020 | 10.4244/EIJ-D-19-01079
Fractional flow reserve-guided multivessel angioplasty in myocardial infarction: three-year follow-up with cost benefit analysis of the Compare-Acute trial
Smits P, Laforgia P, Abdel-Wahab M, Neumann F, Richardt G, Boxma-de Klerk B, Lunde K, Schotborgh C, Piroth Z, Horak D, Wlodarczak A, Frederix G, Omerovic E
June 25, 2020 | 10.4244/EIJ-D-20-00012
Coronary interventions
The obesity paradox revisited: body mass index and ­long-term outcomes after PCI from a large pooled patient-level database
Wolny R, Maehara A, Liu Y, Zhang Z, Mintz G, Redfors B, Madhavan M, Smits P, von Birgelen C, Serruys P, Mehran R, Leon M, Stone G
January 17, 2020 | 10.4244/EIJ-D-19-00467
Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention
Brener S, Leon M, Serruys P, Smits P, von Birgelen C, Mehran R, Kirtane A, Witzenbichler B, Rinaldi M, Metzger C, Mazzaferri E, Zhang Z, Stone G
August 9, 2019 | 10.4244/EIJ-D-19-00262
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
Asano T, Katagiri Y, Collet C, Tenekecioglu E, Miyazaki Y, Sotomi Y, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernandez-Antolín R, van de Harst P, Iñiguez A, Janssens L, Smits P, Wykrzykowska J, Ribeiro V, Pereira H, da Silva P, Piek J, Reiber J, von Birgelen C, Sabaté M, Onuma Y, Serruys P
August 3, 2018 | 10.4244/EIJ-D-17-00461
Stents and scaffolds
A prospective randomised trial comparing the novel ridaforolimus-eluting BioNIR stent to the zotarolimus-eluting Resolute stent: six-month angiographic and one-year clinical results of the NIREUS trial
Paradies V, Ben-Yehuda O, Jonas M, Banai S, Iñiguez A, Perlman G, Kandzari D, Stone G, Smits P
May 20, 2018 | 10.4244/EIJ-D-17-00890
First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial
von Birgelen C, Asano T, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernández-Antolín R, van de Harst P, Iñiguez A, Janssens L, Smits P, Wykrzykowska J, Ribeiro V, Pereira H, da Silva P, Piek J, Onuma Y, Serruys P, Sabaté M
April 20, 2018 | 10.4244/EIJ-D-17-00462
Coronary interventions
Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions
Fam J, Ojeda S, Garbo R, Latib A, La Manna A, Vaquerizo B, Boukhris M, Vlachojannis G, van Geuns R, Ezhumalai B, Kawamoto H, van der Sijde J, Felix C, Pan M, Serdoz R, Boccuzzi G, De Paolis M, Sardella G, Mancone M, Tamburino C, Smits P, Di Mario C, Seth A, Serra A, Colombo A, Serruys P, Galassi A, Zijlstra F, Van Mieghem N, Diletti R
June 20, 2017 | 10.4244/EIJ-D-16-00253
Coronary interventions
Potentially increased incidence of scaffold thrombosis in patients treated with Absorb BVS who terminated DAPT before 18 months
Felix C, Vlachojannis G, IJsselmuiden A, Fam J, Smits P, Lansink W, Diletti R, Zijlstra F, Regar E, Boersma E, Onuma Y, van Geuns R
June 2, 2017 | 10.4244/EIJ-D-17-00119
Coronary interventions
Biolimus-eluting versus everolimus-eluting stents in coronary artery disease: a pooled analysis from the NEXT (NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent) and COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) randomised trials
Vlachojannis G, Puricel S, Natsuaki M, Morimoto T, Smits P, Kimura T
March 20, 2017 | 10.4244/EIJ-D-16-00773
Coronary interventions
Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial
Chevalier B, Onuma Y, Van Boven A, Piek J, Sabaté M, Helqvist S, Baumbach A, Smits P, Kumar R, Wasungu L, Serruys P
October 20, 2016 | 10.4244/EIJY16M08_01
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial
Vlachojannis G, Smits P, Hofma S, Togni M, Vázquez N, Valdes M, Voudris V, Puricel S, Slagboom T, Goy J-J, den Heijer P, van der Ent M
July 20, 2015 | 10.4244/EIJV11I3A53
Long-term follow-up of second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction: three-year results of the XAMI trial
Hofma S, Smits P, Brouwer J, Velders M, van't Hof A, Quere M, de Vries C, Van Boven A
March 20, 2015 | 10.4244/EIJY15M01_03
Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH)
Simsek C, Magro M, Onuma Y, Boersma E, Smits P, Dorange C, Veldhof S, Regar E, Serruys P, van Geuns R
June 20, 2014 | 10.4244/EIJV10I2A38
Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months
Serruys P, Onuma Y, Garcia-Garcia H, Muramatsu T, van Geuns R, De Bruyne B, Dudek D, Thuesen L, Smits P, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert K, Rapoza R, Ormiston J
March 20, 2014 | 10.4244/EIJV9I11A217
STEMI patients and non-culprit lesions: what to do and when?
Smits P
December 27, 2013 | 10.4244/EIJV9I8A150
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials
Gogas B, Bourantas C, Garcia-Garcia H, Onuma Y, Muramatsu T, Farooq V, Diletti R, van Geuns R, De Bruyne B, Chevalier B, Thuesen L, Smits P, Dudek D, Koolen J, Windecker S, Whitbourn R, McClean D, Dorange C, Miquel-Hebert K, Veldhof S, Rapoza R, Ormiston J, Serruys P
October 25, 2013 | 10.4244/EIJV9I6A115
A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients
Vranckx P, Verheugt F, de Maat MP, Ulmans V, Regar E, Smits P, ten Berg J, Lindeboom W, Jones R, Friedman J, Reilly P, Leebeek F
January 18, 2013 | 10.4244/EIJV8I9A162
Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials
Kedhi E, Stone G, Kereiakes D, Serruys P, Parise H, Fahy M, Simonton C, Sudhir K, Sood P, Smits P
September 28, 2012 | 10.4244/EIJV8I5A92
Everolimus-eluting stents and paclitaxel-eluting stents in patients presenting with myocardial infarction: insights from the two-year results of the COMPARE prospective randomised controlled trial
Kedhi E, Gomes M, Joesoef K, Wassing J, Goedhart D, McFadden E, Smits P, investigators t
April 20, 2012 | 10.4244/EIJV7I12A217

Latest news

EDITORIAL
A State-of-the Art and Mini Focus on Intracoronary OCT; Thrombectomy for Acute Ischaemic Stroke; and more…
June 11, 2021
NEW
Intracoronary OCT: State of the Art and Future Directions
Ziad A. Ali et al.
June 11, 2021
PCR Companion attending EuroPCR? Activate your free subscription!
May 28, 2021
TRIALS BOOK
Access the full Trials Book 2021
(Thanks to the support of Biotronik)
May 18, 2021
JAA
This Week's JAA's: ABSORB DAPT, OFR in predicting post-PCI FFR and more...
June 8, 2021
NEW
Joint EAPCI/ACVC expert consensus on pVADs
Alaide Chieffo et al.
May 31, 2021
JAA
New JAA's: Impact of HPR on clopidogrel monotherapy and more...
May 25, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke